Einar Björgvinsson

Artiklar

Journal article: JOURNAL OF INTERNAL MEDICINE. 2026
Perioperative immune checkpoint inhibitor therapy across tumors: Insights and shared lessons from a rapidly evolving field
Bjorkstrom K; Matikas A; Svedman FC; Bjorgvinsson E; Zupancic M; Villabona L; Eriksson H; Skribek M; Fernebro J; Lindskog M; Frodin J-E; Ullen A; Ekman S; Helgadottir H
Article: HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. 2025;47(2):586-598
"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome
Mercke C; Friesland S; Berglund A; Johansson GW; Margolin G; Gubanski M; Bjorgvinsson E; Nilsson J
Article: FRONTIERS IN ONCOLOGY. 2020;10:1647
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
Onjukka E; Mercke C; Bjorgvinsson E; Embring A; Berglund A; Alexandersson von Dobeln G; Friesland S; Gagliardi G; Lenneby Helleday C; Sjodin H; Lax I
Article: BREAST CANCER RESEARCH AND TREATMENT. 2013;140(2):375-384
Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.
Tryggvadottir L; Olafsdottir EJ; Olafsdottir GH; Sigurdsson H; Johannsson OT; Bjorgvinsson E; Alexiusdottir K; Stefansson OA; Agnarsson BA; Narod SA; Eyfjord JE; Jonasson JG

Meeting abstract: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(15):6077
Randomized phase II study with or without induction chemotherapy combined with accelerated high dose radiotherapy and cetuximab in locally advanced unresectable HPV positive squamous cell carcinoma of the head and neck.
Friesland S; Mercke C; Sjodin H; von Dobeln G; Carstens H; Margolin G; Bjorgvinsson E; Lax I; Gubanski M; Embring A; Da Silva PFN; Nilsson J; Wickart-Johansson G
Conference publication: RADIOTHERAPY AND ONCOLOGY. 2019;133:S322-S323
Modelling of xerostomia after radiotherapy for head and neck cancer: a registry study
Onjukka E; Mercke C; Discacciati A; von Dobeln GA; Bjorgvinsson E; Carstens H; Friesland S; Gagliardi G; Helleday CL; Sjodin H; Johansson GW; Lax I
Letter: LEUKEMIA & LYMPHOMA. 2017;58(5):1219-1223
Outcomes of second-line treatment in chronic lymphocytic leukemia - a population-based study from a well defined geographical region between 2003 and 2013
Asklid A; Winqvist M; Sylvan SE; Mattsson A; Bjorgvinsson E; Soltoft F; Repits J; Diels J; Osterborg A; Hansson L
Conference publication: BLOOD. 2015;126(23):4166
Outcome of Second Line Treatment in Patients with Chronic Lymphocytic Leukemia Did Not Improve 2002-2013: A Population-Based Study from a Well-Defined Geographic Region
Asklid A; Mattsson A; Bjorgvinsson E; Winqvist M; Sylvan SE; Soltoft F; Repits J; Diels J; Osterborg A; Hansson L